CR20120238A - FORMULATION OF PACKAGING TO PREVENT THE INSOLUBILITY OF THE COMPOSITIONS CONTAINING QUITOSAN - Google Patents

FORMULATION OF PACKAGING TO PREVENT THE INSOLUBILITY OF THE COMPOSITIONS CONTAINING QUITOSAN

Info

Publication number
CR20120238A
CR20120238A CR20120238A CR20120238A CR20120238A CR 20120238 A CR20120238 A CR 20120238A CR 20120238 A CR20120238 A CR 20120238A CR 20120238 A CR20120238 A CR 20120238A CR 20120238 A CR20120238 A CR 20120238A
Authority
CR
Costa Rica
Prior art keywords
prevent
quitosan
insolubility
formulation
packaging
Prior art date
Application number
CR20120238A
Other languages
Spanish (es)
Inventor
Evertt J Nichols
James R Scott
John P Carroll
Original Assignee
Halosource Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Halosource Inc filed Critical Halosource Inc
Publication of CR20120238A publication Critical patent/CR20120238A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/18Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/20Oxides; Hydroxides
    • C08K3/22Oxides; Hydroxides of metals
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65BMACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B63/00Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged
    • B65B63/08Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for heating or cooling articles or materials to facilitate packaging
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/30Sulfur-, selenium- or tellurium-containing compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/34Silicon-containing compounds
    • C08K3/36Silica
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/09Carboxylic acids; Metal salts thereof; Anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/16Nitrogen-containing compounds
    • C08K5/17Amines; Quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00Materials not provided for elsewhere

Abstract

Se proporcionan formulaciones, métodos, y productos para evitar o reducir la insolubilización de composiciones que contienen quitosán. Al emplear las realizaciones discutidas aquí, se puede conservar la capacidad de una composición que contiene quitosán para solubilización adecuada en un momento deseado.Formulations, methods, and products are provided to prevent or reduce the insolubilization of chitosan-containing compositions. By employing the embodiments discussed herein, the ability of a chitosan-containing composition for adequate solubilization at a desired time can be preserved.

CR20120238A 2009-10-27 2012-05-08 FORMULATION OF PACKAGING TO PREVENT THE INSOLUBILITY OF THE COMPOSITIONS CONTAINING QUITOSAN CR20120238A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25541309P 2009-10-27 2009-10-27

Publications (1)

Publication Number Publication Date
CR20120238A true CR20120238A (en) 2012-06-22

Family

ID=43970651

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20120238A CR20120238A (en) 2009-10-27 2012-05-08 FORMULATION OF PACKAGING TO PREVENT THE INSOLUBILITY OF THE COMPOSITIONS CONTAINING QUITOSAN

Country Status (5)

Country Link
US (2) US20120234703A1 (en)
CA (1) CA2779242A1 (en)
CO (1) CO6541608A2 (en)
CR (1) CR20120238A (en)
WO (1) WO2011056510A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014071240A1 (en) 2012-11-01 2014-05-08 Halosource, Inc. Water treatment composition and method of using same
CN108795007B (en) * 2018-06-06 2020-04-21 中山市亿丰塑胶制品有限公司 Processing technology of flame-retardant weather-resistant PC/ABS composite material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5811553A (en) * 1981-07-11 1983-01-22 Katayama Chem Works Co Ltd Easily dispersible composition of water-soluble polymer
ZA827728B (en) * 1981-11-17 1983-08-31 Nestle Sa A process for the production of enzymatically active biocatalysts and the products obtained
DE3676235D1 (en) * 1985-06-04 1991-01-31 Teijin Ltd DRUG PREPARATION WITH DELAYED DELIVERY OF ACTIVE SUBSTANCE.
JPH07213588A (en) * 1994-01-27 1995-08-15 Nippon Kayaku Co Ltd Chitosan preservation
US6258755B1 (en) * 1998-12-28 2001-07-10 Venture Innovations, Inc. Chitosan-containing well drilling and servicing fluids
US6378224B1 (en) * 1999-10-15 2002-04-30 Carol M. Qualkinbush Apparatus for removing odor and moisture from footwear and the like
SE522529C2 (en) * 2001-04-12 2004-02-17 Medicarb Ab Effervescent solid composition used for treating dermal wounds comprises chitosan or component releasing carbon dioxide in acidic environment
US6749748B1 (en) * 2001-12-28 2004-06-15 Vanson Halosource, Inc. Methods for reducing the amount of contaminants in water
KR100454228B1 (en) * 2002-03-15 2004-10-26 한국식품개발연구원 A feed additive for cultured fish
WO2008063468A2 (en) * 2006-11-13 2008-05-29 The Procter & Gamble Company Water-soluble detergent pouch
GB0625813D0 (en) * 2006-12-22 2007-02-07 Advanced Biopolymers As Process
TWI331053B (en) * 2006-12-22 2010-10-01 Taiwan Textile Res Inst A water-treatment particle and a method of manufacturing thereof

Also Published As

Publication number Publication date
CO6541608A2 (en) 2012-10-16
US20120234703A1 (en) 2012-09-20
CA2779242A1 (en) 2011-05-12
WO2011056510A2 (en) 2011-05-12
US20160137752A1 (en) 2016-05-19
WO2011056510A3 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
AU2009215514A9 (en) Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
AR054581A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE LEVETIRACETAM AND PROCESS FOR PREPARATION
AR077199A1 (en) PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE FOR EMERGENCY ANTI-CONCEPTION
CA2757418C (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making the same
NZ596254A (en) Cleanser compositions and methods for using the same comprising linalool, hinokitiol, diol and surfactant
BR112014005134A2 (en) fast dissolving pharmaceutical composition
MX2011010415A (en) Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereof.
BR112012011328A2 (en) akt inhibitors
MY156518A (en) Borinic compositions
MX2010005516A (en) Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent, methods for preparing same and uses thereof.
NI201000189A (en) SOLID MEDICINE FORMULATION WITH DELAYED RELEASE.
CL2011002928A1 (en) Use of a composition comprising at least one glucan, at least one fucan, or at least one glucan and at least one fucan, to improve or maintain the gastrointestinal health or function of a progeny of a maternal animal by administration to the maternal animal and the composition used.
WO2011161396A3 (en) Disinfectant composition
AR111471A2 (en) SYNERGIC COMBINATION COMPOSITION
UY31128A1 (en) FORMULATION OF NEVIRAPINE OF PROLONGED RELEASE
PA8846401A1 (en) ANTIBIOTIC SYNERGISM
CO6541608A2 (en) FORMULATION OF PACKAGING TO PREVENT THE INSOLUBILITY OF THE COMPOSITIONS CONTAINING QUITOSAN
AU2012345659A8 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
CL2012003250A1 (en) Use of a galactolipid in combination with ascorbic acid and / or a derivative thereof that serves to protect a composition against oxidation; method for the preparation of the composition, composition; and product.
BR112012012816A2 (en) low-abrasion, high-clean silica materials to modulate the capture and release of hydrophobic actives in dental formulations
ECSP10010398A (en) AGRICULTURAL COMPOSITIONS
CR10382A (en) 2-ALCOXI-3,4,5-TRIHIDROXI-ALQUILAMIDA-BENZAZEPINAS, ITS PREPARATION, COMPOSITIONS THAT CONTAIN AND USE
MA33055B1 (en) NOVEL COMBINATION OF ACTIVE INGREDIENTS CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY AND COLCHICOSIDE DERIVATIVE
CR10390A (en) DERIVATIVES OF 2-ALCOXI-3,4,5-TRIHIDROXI-ALQUILAMIDA, ITS PREPARATION, COMPOSITIONS THAT CONTAIN THEM AND USE
GT200800254A (en) 2-ALCOXI-3,4,5-TRIHIDROXI-ALQUILAMIDA-BENZOTIAZEPINAS, ITS PREPARATION, COMPOSITIONS THAT CONTAIN THEM AND USE.